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Abstract 
Research to quantify the potency of larval excretion/secretion from Lucilia sericata 
using liquid culture assays has produced contradictory results. In this study, viable 
counting was used to investigate the effectiveness of excretion/secretion against 
three marker bacterial species (Pseudomonas aeruginosa, Staphylococcus aureus, 
Escherichia coli) and the effects of varying growing conditions in assays. Results 
demonstrate that factors such as number of larvae, species of bacteria and addition 
of nutrient influence its antibacterial potency. Therefore a standardised method 
should be employed for liquid culture assays when investigating the antibacterial 
activity of larval excretion/secretion from L. sericata. 
 
Keywords: ANTIBACTERIAL; INSECTS; MAGGOT DEBRIDEMENT THERAPY; 
WOUNDS 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
 
1. Introduction  
 The reintroduction of maggot debridement therapy into modern wound 
management has prompted further research into the antibacterial effectiveness of the 
blowfly, Lucilia sericata (Meigen). A number of studies have demonstrated that 
bacteria, such as Escherichia coli are consumed and then eradicated in the acidic 
midgut of L. sericata larvae (Robinson and Norwood, 1934; Greenberg, 1968; 
Mumcuoglu et al., 2001; Daeschlein et al., 2007) and that the externalised larval 
excretion/secretion (ES) can reduce the viability of a number of Gram-negative and 
Gram-positive organisms (Simmons, 1935; Thomas et al., 1999; Bexfield et al., 2004; 
Kerridge et al., 2005; Bexfield et al., 2008; Jaklic et al., 2008; van der Plas et al., 
2008; Cazander et al., 2009a; Harris et al., 2009).  
 To date, the quantification of the antibacterial effectiveness of L. sericata ES 
has been most successful using liquid culture assays (LCAs) (Bexfield et al., 2004; 
Jaklic et al., 2008). However, a review of studies provided contradictory results on 
the duration and potency of antibacterial activity against common wound bacterial 
species. For example, some research demonstrated L. sericata ES inhibited growth 
of Pseudomonas aeruginosa over a 24-hour period at an estimated concentration of 
5g larvae per ml (Bexfield et al., 2004) whereas others reported a prolonged lag 
phase of 5-6 hours at an estimated concentration of 7.5 g larvae per ml (Jaklic et al., 
2008) or either partial or no inhibition of P. aeruginosa (Thomas et al., 1999; 
Cazander et al., 2009b). 
 The pH of larval ES has in part been thought to influence its antibacterial 
effectiveness (Thomas et al., 1999; Cazander et al., 2009b; Gwatkin and Fallis, 
1938). However, studies have since proved this not to be the case (Bexfield et al., 
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2004; Barnes et al., 2010). Therefore the contradictions reported in LCAs to date 
may be a result of variation in the experimental techniques used together with 
differences in the bacterial growth stage inoculated, size of inocula, the type and 
amount of nutrient employed in the assays, along with the detailed methodology used 
to collect the ES.  
 Experiments in our laboratory have demonstrated that L. sericata ES is able to 
inhibit growth of bacteria in both stationary and exponential phases. Under our 
conditions ES was equally able to reduce the viability of inocula of 20 µl and 100 µl 
(105 CFU/ml) (unpublished data). Therefore the main focus of our investigation was 
to assess the effects of different larval concentrations and varying nutrients on the 
antibacterial potency of L. sericata ES against three organisms commonly found in 
the wound environment, Staphylococcus aureus, E. coli and P. aeruginosa (Bowler et 
al., 2001). These results were then utilised to test a new liquid culture assay method 
with which to standardise future work.   
 
2. Materials and methods 
2.1 Larval ES preparation 
Colonies of L. sericata were maintained under a lighting regime of 16:8 (L: D) hours 
and a temperature of 25°C ± 3 °C. Porcine liver was used for both oviposition and to 
rear the resulting larvae. The ES was collected from third instar larvae by adding a 
standardised amount of sterile, deionised water (dH2O) to a weighed sample of 
larvae (for example, 1g of larvae per ml of dH2O). Larvae were incubated at 30 °C for 
60 minutes after which the ES was collected and micro-centrifuged at 7826 x g for 
five minutes and filtered (0.20 µm) to remove large particles and bacteria. 
5 
 
 
 
2.2 Liquid culture assays 
One colony was removed from a stock plate of nutrient agar and inoculated in 20 ml 
sterile tryptone soya broth (TSB). The broth was incubated with shaking (180 RPM) 
at 37 °C for 17 hours; the optimal growth conditions specified for the three reference 
bacteria. A sample of 0.1 ml of the overnight bacterial culture was transferred to 10 
ml TSB broth and incubated at 37 °C with shaking (180 RPM) until the optical density 
reading at 600 nm was in the range of 0.24-0.25 (exponential phase).  
 L. sericata ES was separated into 4ml aliquots. Twenty l of bacterial culture 
in TSB (exponential phase) was added to the ES and samples incubated at 37 °C, 
with aeration, for 24 hours. Bacterial viable counts were used to measure bacterial 
growth over the experimental period and were taken at 0, 4, 8 and 24 hours after 
inoculation. Serial dilutions of the sample in sterile dH2O were made and three 
aliquots (20 l) of each dilution were spotted onto nutrient agar plates. Plates were 
then incubated at 37 °C for 20-24 hours. Each experiment was replicated three times 
on at least two separate occasions.  
 
2.4 The effect of concentration on ES 
Bacterial viable counts were used to assess the antibacterial potency of four different 
larval concentrations of ES (1-4 g/ml) against the three bacterial reference species; S. 
aureus (ATCC 25923), E. coli (ATCC 25922) and P. aeruginosa (ATCC 27853).  
 
2.5 The effect of nutrient on ES 
The antibacterial potency of ES (3 g/ml) either with or without the addition of 10% 
TSB against the same three bacterial reference species was also determined using 
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viable counts. The addition of nutrient was intended to reflect conditions in a wound 
in which necrotic tissue provides a bacterial nutritional source. 
 
2.6 Quantification of the antibacterial activity of ES using a suitable liquid 
culture assay 
The antibacterial potency of 10% TSB and ES (3 g/ml) compared to 10% TSB and 
dH2O (a control) was assessed by viable counting to determine the suitability of these 
conditions for quantification of antibacterial activity in ES in LCAs.  
 
2.7 Statistical analyses 
Statistical analyses were performed on mean Log10 transformed data sets using 
SPSS (version 14.0). The Bonferroni test was used as a post hoc test on those 
significantly different data sets confirmed by ANOVA. The results are presented as 
typical growth curves constructed from mean bacterial counts over the 24-hour 
experimental period.  
 
3. Results  
3.1 The effect of concentration of ES on antibacterial activity 
The concentration of ES had a significant effect on the growth of the bacteria tested 
(ANOVA: F3,12=309.89, p<0.001). The ES, at a concentration of 1 g/ml and 2 g/ml, 
was significantly less effective at inhibiting bacterial growth compared to the higher 
concentrations tested (p<0.001). Although there was no significant difference 
between the antibacterial activity of ES at a concentration of 3 g/ml and 4 g/ml 
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(p=0.210). Additionally, L. sericata ES varied in its potency dependent upon the 
bacterial species tested (ANOVA: F2,12=437.06, p<0.001).  
 At a concentration of 1 g/ml L. sericata ES failed to inhibit growth of S. aureus 
(Fig. 1) but inhibited growth of E. coli (Fig. 2) and P. aeruginosa (Fig. 3) for 6-8 hours. 
At 2 g/ml the initial count of E. coli and P. aeruginosa was reduced below the limit of 
detection (103) (LOD) in six hours whereas the initial count of S. aureus in ES was 
only partially reduced 8 hours after inoculation. The higher concentrations of 3 g/ml 
and 4 g/ml reduced the viability of E. coli below the LOD in two hours, P. aeruginosa 
in four hours and S. aureus over 24 hours.  
 
3.2 The effect of nutrient on the antibacterial activity of ES 
Addition of nutrient significantly influenced the ability of ES to control bacterial growth 
(ANOVA: F1,6=48.08, p<0.001). This effect varied according to the particular species 
of bacteria used (ANOVA: F2,6=321.44, p<0.001).  
 S. aureus cultures were reduced below the LOD, both with and without added 
nutrient, over a 24 hour experimental period. However, the mean bacterial counts in 
ES without added nutrient were lower than in samples where nutrient was present 
(Fig. 4). Added nutrients delayed the reduction in viability of P. aeruginosa by two 
hours but the addition of nutrient did not affect the ability of ES to inhibit E. coli 
growth (Fig. 4).  
 
3.3 Quantification of antibacterial activity using a suitable liquid culture assay 
There was significantly more bacterial growth in control samples (dH2O/TSB) 
compared to that in ES samples (ES/TSB) (ANOVA: F1,6 = 504.53, p<0.001). 
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Bacterial numbers in the control vessels reached 107-109 over the 24-hour 
experimental period whereas counts were reduced below the LOD in all ES samples 
(Fig. 5). Therefore inoculation into ES resulted in >50% reduction in growth 
compared to controls. This was true for all bacterial species tested (ANOVA: F2,6 = 
1.12, p=0.386).  
 
4. Discussion 
Increasing concentration of larval L. sericata ES and the presence of additional 
nutrient influenced antibacterial activity. Consequently, the different concentrations of 
ES and types of media employed in the LCAs will have contributed to the variation in 
results to date reported by previous researchers (Thomas et al., 1999; Bexfield et al., 
2004; Jaklic et al., 2008; Cazander et al., 2009b).  
 In the present study L. sericata ES was more potent against some species of 
bacteria than others. The susceptibility sequence to L. sericata ES in our research 
was E. coli followed by P. aeruginosa and then S. aureus. These results support 
work indicating L. sericata larvae were more efficient at eradicating specific bacterial 
species from a wound (Jaklic et al., 2008). However, the fact that E. coli was more 
susceptible to L. sericata ES than both S. aureus and P. aeruginosa does not support 
research which revealed that Gram-positive bacteria were more sensitive to L. 
sericata ES than Gram-negative bacteria (Thomas et al., 1999; Kerridge et al., 2005).  
 From our results and those of other researchers, it is vital to select optimal 
conditions in which to detect antibacterial activity in L. sericata ES (Thomas et al., 
1999; Bexfield et al., 2004; Jaklic et al., 2008; Cazander et al., 2009b). Whilst it is 
important to use media with a sufficiently high nutritional content for normal bacterial 
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growth in the control vessel, it is also important that the amount and type of media 
employed is not detrimental to the antibacterial activity exhibited by the ES. Addition 
of nutrients such as 33% TSB, 50% brain heart infusion broth and 50% Mueller 
Hinton broth, where poor control is reported (Thomas et al., 1999; Jaklic et al., 2008; 
Cazander et al., 2009b) would have influenced the effectiveness of antibacterial 
activity in ES. This contrasts with inhibition of bacterial growth achieved over a 24-
hour period in media low in nutrient such as in 10% peptone water (Bexfield et al., 
2004). Results from the liquid culture assay in this study show that the addition of 
10% TSB to ES, whilst prolonging time taken to achieve reduction in viability of 
bacterial cells, all demonstrate the actual antibacterial potency of native ES over a 
24-hour period. Experiments in our laboratory have also demonstrated that the 
antibacterial activity in ES is produced continuously (unpublished data) and might, 
therefore in vivo, be considered to be more effective than that provided by a sole 
application in vitro. 
 It is important that LCAs are conducted over periods of time suitable for the 
demonstration of antibacterial activity. A period of 24 hours allows for any lag phase 
or inhibition period to become apparent in turbidometric studies. In addition, it also 
gives a viable count assay the opportunity to demonstrate any regrowth in 
populations maintaining viability that may have just remained below detection limits 
for a short period of time. 
 Additionally, the numbers of larvae used must be sufficient to produce 
significant antibacterial activity since some components present in ES are also used 
for bacterial growth. This is demonstrated by regrowth in samples at a low larval 
collection concentration.  The results also suggest that there is a finite number of 
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larvae required for optimal antibacterial activity, at least in vitro. The average weight 
of a third instar larva in our study was 0.06 g and at a larval concentration of 3g/ml, 
approximately 50 larvae provide one ml of ES suspension. Therefore, 4 ml aliquots of 
ES used in this study would equate to 200 larvae and presumably in a wound 
environment, 200 third instar larvae would be required to produce an optimal 
antibacterial effect. This is much lower than the minimum maggot quantities (1 pot = 
300 maggots) recommended for debridement in the UK (LarvE calculator: 
http://www.zoobiotic.co.uk/larve-calculator.htm).  
 In conclusion, it is necessary that LCA methods quantifying antibacterial 
activity in L. sericata are standardised so that results are consistent and comparable. 
This study also has implications for maggot debridement therapy, demonstrating that 
the number of larvae and conditions of the interaction between larvae and bacteria 
are critical to the outcome at least in vitro. The possibility of assessing a wound and 
reducing the number of larvae may be helpful in reducing numbers escaping when 
applying larvae directly to a wound. Additionally, the research indicates that it is 
important to take into account the size of the wound, the species of bacteria and the 
percentage of necrotic tissue present before applying larvae for therapeutic purposes.  
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Figures and legends 
Barnes, Gennard and Dixon (Top) 
 
 
Fig. 1: Mean viable counts of S. aureus in four different larval concentrations of 
L. sericata ES (1-4 g/ml) over a 24-hour experimental period. Error bars indicate 
standard error. 
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Barnes, Gennard and Dixon (Top) 
 
 
Fig. 2: Mean viable counts of E. coli in four different larval concentrations of L. 
sericata ES (1-4 g/ml) over a 24-hour experimental period. Error bars indicate 
standard error. Mean viable counts for 3g/ml and 4g/ml are superimposed on 
the graph. 
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Barnes, Gennard and Dixon (Top) 
 
 
Fig. 3: Mean viable counts of P. aeruginosa in four different larval 
concentrations of L. sericata ES (1-4 g/ml) over a 24-hour experimental period. 
Error bars indicate standard error. 
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Barnes, Gennard and Dixon (Top) 
 
 
Fig. 4: Mean viable counts of S. aureus, E. coli and P. aeruginosa in L. sericata 
ES (3 g/ml) with and without the addition of 10% tryptone soya broth (TSB) over 
a 24-hour experimental period. Error bars indicate standard error. Mean viable 
counts for E. coli in ES and ES/TSB are superimposed on the graph. 
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Barnes, Gennard and Dixon (Top) 
 
 
Fig. 5: Antibacterial activity of L. sericata ES (3g/ml) against S. aureus, P. 
aeruginosa and E. coli compared to normal growth in a control produced from 
the mean counts over a 24-hour experimental period. Error bars indicate 
standard error. 
